Paraneoplastic syndrome is a rare immune-mediated complication which is caused by a remote effect of cancer that may be occult.
Paraneoplastic syndromes present in a different clinical manifestations, as an encephalitis, Lambert-Eaton syndrome, common abdominal symptoms which occurs commonly with neuroblastoma such as diarrhea, severe constipation and chronic flatulence, myelopathies, movement disorders, new-onset hyperglycemia, intrahepatic cholestasis, endocrine symptoms which produce corticotropin releasing hormone, adrenocorticotropic hormone, and antidiuretic hormone, and other various symptoms.
Antibodies to Ma2 (also known as anti-TA), NMDA-receptor, anti-Hu, anti-metabotropic glutamate receptor 5 (mGluR5) antibodies, anti-GABA B and anti-glutamate receptor were found in many patients with paraneoplastic limbic encephalitis, although this marker may be absent in some patients. It may be observed with solid tumors, in primary or metastatic occult and gross cancers. In men around the age of 40, it has been found to be caused most commonly by testicular tumors, but overall underlying lung cancer is the most common cause; usually, paraneoplastic limbic encephalitis with anti Ta antibodies is associated with small cell lung carcinoma and anti Ta antibodies is associated with testicular tumor in young men, but if the antibodies were negative, diverse tumors, such as lymphoma and leukemia, could be the cause.
It may not be paraneoplastic and presents with other autoimmune diseases (DM1), systemic sclerosis, or infections.
Autoimmune encephalitis showed an increase in the prevalence,. One of the subtypes of it is paraneoplastic limbic encephalitis, which is a rare cause of altered mental status in young, but physicians should think of it as a cause of encephalopathy in children. It is one of the neurological paraneoplastic syndromes which occur in less than 1 per 10,000 patients; 50% of patients will have lung cancer, 20% will have testicular tumors, and 8% will have breast cancer.,
Paraneoplastic limbic encephalitis is thought to be caused by an onconeural antibody to cancer that cross-reacts with self-antigen in the neurons and muscles. Although they are considered a cause of this paraneoplastic syndrome, the absence of them does not exclude the syndrome, so further studies are needed to know the exact mechanism of this syndrome.,
An autopsy on a patient with paraneoplastic limbic encephalitis syndrome showed multiple areas of micro-softening in the cerebral cortex which are distributed in the limbic and non-limbic areas with lymphocytic infiltration in the intraparenchymal vessels. Other findings were T-cell dominated inflammation, neural loss, and microglial activation.
It is is a rare paraneoplastic syndrome that affects the medial temporal lobe and may be presented with cognitive dysfunction with a subacute beginning, change in the personality, seizure in partial and generalized type, irritability, hallucinations, disorientation, limbic paresis, and disruption of consciousness and short-term memory loss,,. A study of patients with this syndrome showed that most of the patients presented with an altered level of consciousness. Usually, early manifestations are psychiatric symptoms, so many patients may be treated in the psychiatric ward before making the diagnosis of paraneoplastic limbic encephalitis.
Symptoms of this syndrome usually precede the diagnosis of the tumor. It may appear to be complications of chemotherapy, so when this syndrome is suspected, a complete history and physical examination should be done to determine which cancer is the cause. Cognitive function may be accessed through a mini mental-state examination, clock test, or instrumental activity of daily living. Also, this syndrome may be a part of the larger syndrome in which the brain stem and spinal cord are also involved in the inflammatory process.
Any patient who is suspected to have paraneoplastic limbic encephalitis should undergo the following tests:
Other tests may be done such as PET-CT which will show abnormal metabolic activities in the limbic system.
Diagnosis is difficult and should be by exclusion because clinical markers are often absent. A study on 1047 patients used the following criteria to diagnose paraneoplastic limbic encephalitis. The patient should achieve all of the following 4 points to make the diagnosis in this study:
Not all of the patients will fulfill these criteria, but the diagnosis of paraneoplastic limbic encephalitis also may be done in the presence of neuropathological examination.
Other diagnostic criteria which may be used include Graus and Saiz criteria. These include the following:
Managing the tumor causes a gradual improvement of the syndrome's signs and symptoms despite the persistence of the radiological signs, either by chemotherapy or by removing the tumor surgically,, and it’s considered as the first line of treatment. Supportive care is required in the patients, and other options include high doses of corticosteroid, plasma exchange, high dose immunoglobulin, immunosuppressive drugs such as azithromycin, and rituximab. In anti-NMDA associated disease, bortezomib may be used, especially in refractory cases.,,,,,
A combination of these drugs may be applied in some patients.,, But studies show that treating the tumor appeared to be more effective than any other options, and steroids may be sometimes ineffective.
The replacement fluid in plasma exchange may be human albumin or fresh frozen plasma; some complications may be seen such as hypotension, allergic reactions, mild anemia, hypocalcemia and catheter placement complications.,,,
The diagnosis of paraneoplastic limbic encephalitis must be done mainly by exclusion. Other diseases which may present with similar signs and symptoms must be excluded before making the diagnosis, such as tumors like glioblastoma and hypothalamic tumors, epilepsy, dementia, tuberculosis, viral encephalitis-like herpes, and bornavirus, psychiatric disorders like dissociative disorder, neurological complications from the chemotherapy, and other relevant diseases.
Early diagnosis and treatment of malignant tumors improve the diagnosis and facilitate the clinical recovery.
Patients with anti-hu antibodies were found to have a poor prognosis and multifocal neurological symptoms, and patients with anti-Ta antibodies were found to have a poor prognosis, but patients who do not have autoantibodies in their blood appear to have a better prognosis.
Patients with anti-GABA B receptor may respond to immunosuppressant drugs better than patients with anti-hu patients.
After making the diagnosis of paraneoplastic limbic encephalitis, consultations may be made according to the presented history and physical examination. These may include consulting a gynecologic oncologist, urological oncologist, pulmonologist, or physicians from other specialties. 
Paraneoplastic limbic encephalitis is best managed by an interprofessional team that also includes oncology nurses. Because there are no specific markers, it is a diagnosis of exclsion. In most cases, if the primary malignancy is managed, the paraneoplastic syndrome will resolve. Several biological drugs can be used to control symptoms but cure is not possible until the primary malignancy has been treated.
|||Inuzuka T, [Paraneoplastic neurological syndrome--definition and history]. Brain and nerve = Shinkei kenkyu no shinpo. 2010 Apr [PubMed PMID: 20420169]|
|||Rosenfeld MR,Titulaer MJ,Dalmau J, Paraneoplastic syndromes and autoimmune encephalitis: Five new things. Neurology. Clinical practice. 2012 Sep [PubMed PMID: 23634368]|
|||Czkwianianc E,Zalewska-Szewczyk B,Kobos J,Socha-Banasiak A,Janczar S,Prymus-Kasińska S,Kazanek-Zasada J,Młynarski W, Uncommon reasons of the digestive tract-related paraneoplastic syndromes in children with neuroblastic tumors: three case reports. Contemporary oncology (Poznan, Poland). 2018 [PubMed PMID: 29692663]|
|||Wu J,Ranjan S, Neoplastic Myelopathies. Continuum (Minneapolis, Minn.). 2018 Apr [PubMed PMID: 29613896]|
|||Popławska-Domaszewicz K,Florczak-Wyspiańska J,Kozubski W,Michalak S, Paraneoplastic movement disorders. Reviews in the neurosciences. 2018 Mar 21 [PubMed PMID: 29561731]|
|||Gapp J,Anwar MF,Parekh J,Griffin T, New onset hyperglycemia attributed to renal cell carcinoma. Intractable [PubMed PMID: 29862157]|
|||Bhangoo MS,Cheng B,Botta GP,Thorson P,Kosty MP, Reversible intrahepatic cholestasis in metastatic prostate cancer: An uncommon paraneoplastic syndrome. Molecular and clinical oncology. 2018 Apr [PubMed PMID: 29541472]|
|||Richa CG,Saad KJ,Halabi GH,Gharios EM,Nasr FL,Merheb MT, Case-series of paraneoplastic Cushing syndrome in small-cell lung cancer. Endocrinology, diabetes [PubMed PMID: 29535866]|
|||Reisch N,Reincke M, [Endocrine paraneoplastic syndromes]. Der Internist. 2018 Feb [PubMed PMID: 29387897]|
|||Kubota A,Tajima T,Narukawa S,Yamazato M,Fukaura H,Takahashi Y,Tanaka K,Shimizu J,Nomura K, [Anti-Ma2, anti-NMDA-receptor and anti-GluRε2 limbic encephalitis with testicular seminoma: short-term memory disturbance]. Rinsho shinkeigaku = Clinical neurology. 2012 [PubMed PMID: 22989902]|
|||Inoue T,Kanno R,Moriya A,Nakamura K,Watanabe Y,Matsumura Y,Suzuki H, A Case of Paraneoplastic Limbic Encephalitis in a Patient with Invasive Thymoma with Anti-Glutamate Receptor Antibody-Positive Cerebrospinal Fluid: A Case Report. Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia. 2017 Dec 20 [PubMed PMID: 29269707]|
|||Mauermann ML, Neurologic Complications of Lymphoma, Leukemia, and Paraproteinemias. Continuum (Minneapolis, Minn.). 2017 Jun [PubMed PMID: 28570324]|
|||Gultekin SH,Rosenfeld MR,Voltz R,Eichen J,Posner JB,Dalmau J, Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain : a journal of neurology. 2000 Jul [PubMed PMID: 10869059]|
|||Kobaidze K,Harrison A,Burklin Y,Patidar V,Riccardi M, AUTOIMMUNE LIMBIC ENCEPHALITIS (CASE REPORTS). Georgian medical news. 2017 May [PubMed PMID: 28628018]|
|||Collao-Parra JP,Romero-Urra C,Delgado-Derio C, [Autoimmune encephalitis. A review]. Revista medica de Chile. 2018 Mar [PubMed PMID: 29999106]|
|||Said S,Cooper CJ,Reyna E,Alkhateeb H,Diaz J,Nahleh Z, Paraneoplastic limbic encephalitis, an uncommon presentation of a common cancer: Case report and discussion. The American journal of case reports. 2013 [PubMed PMID: 24116265]|
|||Ando T,Goto Y,Mano K,Nomura F,Kurashige M,Ito M,Mimuro M,Iwasaki Y,Katsuno M,Yoshida M, Paraneoplastic autoimmune encephalitis associated with pleomorphic lung carcinoma: An autopsy case report. Neuropathology : official journal of the Japanese Society of Neuropathology. 2018 May 20 [PubMed PMID: 29781194]|
|||Höftberger R,Lassmann H, Immune-mediated disorders. Handbook of clinical neurology. 2017 [PubMed PMID: 28987176]|
|||Graus F,Escudero D,Oleaga L,Bruna J,Villarejo-Galende A,Ballabriga J,Barceló MI,Gilo F,Popkirov S,Stourac P,Dalmau J, Syndrome and outcome of antibody-negative limbic encephalitis. European journal of neurology. 2018 Aug [PubMed PMID: 29667271]|
|||Nagafuji H,Yokoi H,Fujiwara M,Sato D,Saito K, Paraneoplastic limbic encephalitis associated with mixed olfactory neuroblastoma and craniopharyngioma: A case report and literature review. Medicine. 2018 Jun [PubMed PMID: 29901583]|
|||Herman L,Zsigmond IR,Peter L,Rethelyi JM, [Review of the psychiatric aspects of anti-NMDA (N-methyl-D-aspartic acid) receptor encephalitis, case report, and our plans for a future study]. Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology. 2016 Dec [PubMed PMID: 28259863]|
|||Li H,Zhang A,Hao Y,Guan H,Lv Z, Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: A case report. Medicine. 2018 May [PubMed PMID: 29742721]|
|||Pastuszak Ż,Stępień A,Tomczykiewicz K,Piusińska-Macoch R,Kordowska J,Galbarczyk D,Świstak J, Limbic encephalitis - a report of four cases. Central-European journal of immunology. 2017 [PubMed PMID: 28860940]|
|||Tsunoda Y,Kiwamoto T,Homma S,Yabuuchi Y,Kitazawa H,Shiozawa T,Nakazawa K,Hosaka T,Ishii K,Ishii A,Tamaoka A,Hizawa N, Paraneoplastic limbic encephalitis with late-onset magnetic resonance imaging findings: A case report. Molecular and clinical oncology. 2017 Aug [PubMed PMID: 28781798]|
|||Rao RM,Chipinapi T,Bharadwaj S,Kissell KA, An unusual case of altered mental status in a young woman. North American journal of medical sciences. 2011 Nov [PubMed PMID: 22361499]|
|||Schroeder C,Back C,Koc Ü,Strassburger-Krogias K,Reinacher-Schick A,Gold R,Haghikia A, Breakthrough treatment with bortezomib for a patient with anti-NMDAR encephalitis. Clinical neurology and neurosurgery. 2018 Jun 23 [PubMed PMID: 29960102]|
|||Scheibe F,Prüss H,Mengel AM,Kohler S,Nümann A,Köhnlein M,Ruprecht K,Alexander T,Hiepe F,Meisel A, Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis. Neurology. 2017 Jan 24 [PubMed PMID: 28003505]|
|||Özkale M,Erol I,Özkale Y,Kozanoğlu İ, Overview of therapeutic plasma exchange in pediatric neurology: a single-center experience. Acta neurologica Belgica. 2018 Jun 7 [PubMed PMID: 29882008]|
|||Yücesan C,Arslan O,Arat M,Yücemen N,Ayyildiz E,Ilhan O,Mutluer N, Therapeutic plasma exchange in the treatment of neuroimmunologic disorders: review of 50 cases. Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 2007 Feb [PubMed PMID: 17224307]|
|||Vogrig A,Joubert B,Ducray F,Thomas L,Izquierdo C,Decaestecker K,Martinaud O,Gerardin E,Grand S,Honnorat J, Glioblastoma as differential diagnosis of autoimmune encephalitis. Journal of neurology. 2018 Mar [PubMed PMID: 29383516]|
|||Tappe D,Schlottau K,Cadar D,Hoffmann B,Balke L,Bewig B,Hoffmann D,Eisermann P,Fickenscher H,Krumbholz A,Laufs H,Huhndorf M,Rosenthal M,Schulz-Schaeffer W,Ismer G,Hotop SK,Brönstrup M,Ott A,Schmidt-Chanasit J,Beer M, Occupation-Associated Fatal Limbic Encephalitis Caused by Variegated Squirrel Bornavirus 1, Germany, 2013. Emerging infectious diseases. 2018 Jun [PubMed PMID: 29774846]|
|||Attademo L,De Falco S,Rosanova M,Esposito M,Mazio F,Foschini F,Santaniello A,Fiore G,Matano E,Manganelli F,Carlomagno C, A case report of limbic encephalitis in a metastatic colon cancer patient during first-line bevacizumab-combined chemotherapy. Medicine. 2018 Mar [PubMed PMID: 29489644]|
|||Shimoyama Y,Umegaki O,Agui T,Kadono N,Minami T, Anti-NMDA receptor encephalitis presenting as an acute psychotic episode misdiagnosed as dissociative disorder: a case report. JA clinical reports. 2016 [PubMed PMID: 29497677]|
|||Shen K,Xu Y,Guan H,Zhong W,Chen M,Zhao J,Li L,Wang M, Paraneoplastic limbic encephalitis associated with lung cancer. Scientific reports. 2018 May 1 [PubMed PMID: 29717222]|
|||Inuzuka T, [Limbic encephalitis: etiology, pathogenesis, diagnosis and therapy]. Rinsho shinkeigaku = Clinical neurology. 2004 Nov [PubMed PMID: 15651295]|
|||Bloch MH,Hwang WC,Baehring JM,Chambers SK, Paraneoplastic limbic encephalitis: ovarian cancer presenting as an amnesic syndrome. Obstetrics and gynecology. 2004 Nov [PubMed PMID: 15516442]|
|||van Altena AM,Wijnberg GJ,Kolwijck E,de Hullu JA,Massuger LF, A patient with bilateral immature ovarian teratoma presenting with paraneoplastic encephalitis. Gynecologic oncology. 2008 Feb [PubMed PMID: 18029289]|